| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/20/2008 | CN100412058C Process for synthesizing bis-indolyl alkyl compounds |
| 08/19/2008 | US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts |
| 08/19/2008 | US7414141 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414063 e.g. 2-(2-bromo-4-fluoro-phenoxy)-ethyl]-[2-(isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester; serine/threonine kinase inhibitor; anticarcinogenic agent; solid tumor, leukemia |
| 08/19/2008 | US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | US7413854 Method for synthesising templated molecules |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/14/2008 | WO2008098058A1 Pi 3-kinase inhibitors and methods of their use |
| 08/14/2008 | WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096127A2 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators |
| 08/14/2008 | WO2008096094A1 Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators |
| 08/14/2008 | WO2008095852A1 Bronchorelaxing arylamides |
| 08/14/2008 | WO2008095293A1 [1,2,3] triazolyl substituted coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008095292A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008067390A9 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| 08/14/2008 | WO2008038136A3 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
| 08/14/2008 | WO2008019292A3 Compositions and methods for potentiating antibiotic activity |
| 08/14/2008 | US20080194826 4-aminopiperidines react with 2-furancarboxylic acid or 2-furoyl chloride; opiod antagonist |
| 08/14/2008 | US20080194638 Bioavailable formulations of heterocyclic compounds |
| 08/14/2008 | US20080194629 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors |
| 08/14/2008 | US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194578 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| 08/14/2008 | US20080194549 Organic Compounds |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677481A1 Triazole compounds that modulate hsp90 activity |
| 08/14/2008 | CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | CA2675558A1 Pi 3-kinase inhibitors and methods of their use |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956019A1 Benzoquinazoline derivatives |
| 08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
| 08/13/2008 | EP1954694A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| 08/13/2008 | EP1954693A1 Beta-secretase modulators and methods of use |
| 08/13/2008 | EP1954683A1 2-(phenyl or heterocyclic)-1h-phenantrho(9,10-d)imidazoles as mpges-1 inhibitors |
| 08/13/2008 | EP1954682A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1020445B1 Fused pyridine derivatives |
| 08/13/2008 | CN101243079A Tricyclic opioid modulators |
| 08/13/2008 | CN101243077A New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101243076A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101243073A Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor |
| 08/13/2008 | CN101243072A Piperidine derivatives useful as histamine H3 antagonists |
| 08/13/2008 | CN101243071A Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 08/13/2008 | CN101243065A Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis |
| 08/13/2008 | CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101240001A 2'-fluoro nucleotide |
| 08/13/2008 | CN101239971A Biphenyl derivatives |
| 08/13/2008 | CN101239970A Biphenyl derivatives |
| 08/13/2008 | CN101239969A Biphenyl derivatives |
| 08/13/2008 | CN101239968A Biphenyl derivatives |
| 08/13/2008 | CN101239954A Triazine compounds and triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers |
| 08/13/2008 | CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411069 For modulating sleep; sleep disorders such as sleep apnea or insomnia |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7410998 Inhibitors of NADH:ubiquinone oxidoreductase |
| 08/12/2008 | US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410980 Performing crystallization by using an organic solvent selected from a ketone solvent, a nitrile solvent, and a mixture thereof, or a mixture of organic solvent and water; acetone or acetonitrile can be preferably used as the organic solvent |
| 08/12/2008 | US7410974 Halogenated Quinazolinyl nitrofurans as antibacterial agents |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/07/2008 | WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 08/07/2008 | WO2008094574A2 Furanone compounds and methods of making and using the same |
| 08/07/2008 | WO2008094056A1 Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8 -di fluorochroman- s -yl ) -1, 3-dihydroimidazole-2-thione |
| 08/07/2008 | WO2008094055A1 Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1, 3-dihydroimidazole-2-thione |
| 08/07/2008 | WO2008094054A2 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders |
| 08/07/2008 | WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| 08/07/2008 | WO2008093064A1 L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS |
| 08/07/2008 | WO2008092942A2 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators |
| 08/07/2008 | WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188527 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
| 08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188472 Indole-2-Carboxylic Acid Hydrazides |
| 08/07/2008 | US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) |